% | $
Quotes you view appear here for quick access.

Sanofi Message Board

  • healthy_johnsons healthy_johnsons Jan 7, 2011 6:07 PM Flag

    Looks like that dolt Viehbacher is showing

    his amateur status and preparing to offer $80/share for Genzyme.

    Genzyme was at $50 when the first offer was made and he's going for a 60% premium now. Close the curtain on this idiot and show him the door.

    Genzyme is a company that is getting increasing competition in the rare disease market, has continuing manufacturing problems, and is selling a pipe dream with projections for their "wonder drug" Campath.

    And the sad thing, Viehbacher is taking it all hook, line, and sinker because he can't think of anything better to do.

    Get this moron out the door, ASAP!!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • That's not the way I read the press release. The $80 figure is only reached with the inclusion of the contingent value clause, if certain milestones concerning sales are reached.

      Anyone else have a take on this?

      • 2 Replies to ghoover1167
      • yeah, that's the way I read this. $80 only if the drug reaches certain sales. Otherwise, it's $69 a share for GENZ. He should just let them go. Nobody else wanted to buy GENZ. That should tell him he's making a mistake. Let GENZ go and fall to $50 again. Screw that stock.

      • There should be a contingent value clause on viehbacher's employment contract.

        if certain milestones of stock price performance are not reached, then he gets kicked out the door by a pepe le pew impersonator.

        lets first start with low expectations. How about a positive return, say anywhere from 0% to 100%. We're still in negative territory since viehbacher was appointed ceo.


37.83-0.84(-2.17%)Sep 29 4:02 PMEDT